4//SEC Filing
Nabulsi Azmi 4
Accession 0001209191-23-042453
CIK 0001783183other
Filed
Jul 16, 8:00 PM ET
Accepted
Jul 17, 5:00 PM ET
Size
10.9 KB
Accession
0001209191-23-042453
Insider Transaction Report
Form 4
Nabulsi Azmi
Chief Operating Officer
Transactions
- Award
Common Stock
2023-07-14+110,000→ 209,567 total - Disposition to Issuer
Stock Option
2023-07-14−150,000→ 0 totalExercise: $39.11Exp: 2031-01-27→ Common Stock (150,000 underlying) - Disposition to Issuer
Stock Option
2023-07-14−70,000→ 0 totalExercise: $32.20Exp: 2030-06-30→ Common Stock (70,000 underlying)
Holdings
- 785,700(indirect: By Trust)
Common Stock
- 3,578.93(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]On July 14, 2023, the Issuer canceled, pursuant to the Issuer's option exchange program, options to purchase 220,000 shares of common stock of the Issuer and in exchange issued to the Reporting Person 110,000 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Includes 1,233.71 shares acquired under the Phathom Pharmaceuticals, Inc. 401(k) plan.
Documents
Issuer
Phathom Pharmaceuticals, Inc.
CIK 0001783183
Entity typeother
Related Parties
1- filerCIK 0001791412
Filing Metadata
- Form type
- 4
- Filed
- Jul 16, 8:00 PM ET
- Accepted
- Jul 17, 5:00 PM ET
- Size
- 10.9 KB